attention%20deficit_hyperactivity%20disorder
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by the presence of impairing levels of inattention, disorganization and/or hyperactivity-impulsivity.
Symptoms that suggest ADHD include hyperactivity, acting without thinking, inattention/daydreaming, fidgety, restless, excessive talking, aggressive behavior, academic underachievement, disorganized and has difficulty in completing tasks.

Follow Up

  • Initially, monitor on a monthly basis until consistent optimal response is noted
    • Then every 3 months in the 1st year of treatment
  • Subsequent follow-up will depend on patient’s response, adherence to treatment strategy, presence of associated conditions
    • Recommended is at least 2 times a year
  • Monitor treatment outcomes and adverse effects (cardiovascular effects, development of tics or seizures, sexual dysfunction, changes in sleep pattern, worsening behavior, stimulant misuse and diversion) by gathering information from parents, teachers and the child
  • Monitor core symptoms using DSM-IV-TR-based ADHD rating scales (eg Vanderbilt ADHD follow-up scales)
  • Re-evaluate the patient when treatment and management plan does not meet desired outcomes
  • Reassess patient at school-leaving age to check for continuity of care into adulthood 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.